HIPK2 and malignant colon neoplasm: This review provides information, mostly with pre-clinical evidence, about a potential candidate biomarker (HIPK2), that might aid in improving the diagnosis and help extend the treatment options of colon cancer cases, thus ameliorating the prognosis of colon cancer patients.